Global Biologic Imaging Reagents Market, By Class (Contrast Reagents, Optical Reagents, Nuclear Reagents), Modality (MRI, Ultrasound, X-ray and CT, Nuclear, Optical Imaging, Others), Application (In Vitro, In Vivo), End User (Diagnostic Laboratories, Imaging Centers, Life Science Companies, Research and Academic Institutes, Others), Industry Trends and Forecast to 2029.
Market Analysis and Size
Over the forecast period, the global biologic imaging reagents market is expected to grow significantly. The biologic imaging reagents are expected to gain traction as they are extremely helpful in detecting biological processes at the molecular level. Furthermore, the market is expected to expand to the growing awareness about these reagents, they are projected to play a significant role across the field of healthcare and other life science industries.
- Data Bridge Market Research analyses that the biologic imaging reagents market is expected to grow at a CAGR of 8.40% during the forecast period. The “MRI and X-ray and CT” accounts for the largest modality segment in the biologic imaging reagents market within the forecasted period.
Biologic imaging reagents basically helps the medical practitioners or researchers to conduct diagnostic or research-based exercises. In general, they aid in the detection of biological processes at the molecular level, as well as assisting medical practitioners/physicians in obtaining diagnostic information for the detection and treatment of diseases, particularly in oncology, cardiology, and neurology.
Biologic Imaging Reagents Market Dynamics
High Prevalence Of Cardiovascular Diseases
The prevalence of various cardiovascular diseases along with neurological diseases and cancer is the most significant factor driving the growth for this market. Rising patient awareness levels across the globe also results in accelerating the overall growth of the market.
The growing demand for diagnostic imaging devices such as MRI and x-ray devices induced by the introduction of digital and portable systems and the implementation of PACS (picture archiving and communication systems) are projected to cushion the growth of the market. Moreover, the increase in expenditure on healthcare and growth in demand for effective procedures and safe medicine is also expected to fuel market growth. Development in biologic imaging reagents and high unmet medical and diagnostic imaging procedure needs also cushions the market’s growth within the forecasted period.
Furthermore, the growing research and development initiatives and increasing awareness levels about nuclear medicine extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Moreover, the radiopharmaceuticals market holds immense growth opportunities in the further expand the biologic imaging reagents market's growth rate in the future.
On the other hand, high cost is expected to obstruct market growth. Also, the high funding requirement are projected to challenge the biologic imaging reagents market in the forecast period of 2022-2029. Additionally, the scarcity of healthcare professionals and limited access to healthcare are also the determinants which affect the market negatively.
This biologic imaging reagents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biologic imaging reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Biologic Imaging Reagents Market
The biologic imaging reagents market has been negatively impacted by the COVID-19. Due to COVID-19 restrictions, demand for imaging reagents has decreased in the biologic imaging industry. The government's various strict guidelines and regulations regarding social distancing and movement restrictions posed as a hurdle for the market’s overall growth. However, the global biological imaging reagents market is expected to recover as respective governing authorities begin to lift these enforced lockdowns across the globe.
Global Biologic Imaging Reagents Market Scope
The biologic imaging reagents market is segmented on the basis of class, modality, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Contrast Reagents
- Optical Reagents
- Nuclear Reagents
On the basis of class, the biologic imaging reagents market is segmented into contrast reagents, optical reagents and nuclear reagents.
- X-ray and CT
- Optical Imaging
On the basis of modality, the biologic imaging reagents market is segmented into MRI, ultrasound, X-ray and CT, nuclear, optical imaging and others. MRI and X-ray and CT are expected grow significantly in the modality segment.
- In Vitro
- In Vivo
On the basis of application, the biologic imaging reagents market is segmented into in vitro and in vivo. The in vitro is sub-segmented into proteomics, genomics and cell biology.
- Diagnostic Laboratories
- Imaging Centres
- Life Science Companies
- Research and Academic Institutes
On the basis of level of end user, the biologic imaging reagents market is segmented into diagnostic laboratories, imaging centers, life science companies, research and academic institutes and others.
Biologic Imaging Reagents Market Regional Analysis/Insights
The biologic imaging reagents market is analysed and market size insights and trends are provided by country, class, modality, application and end user as referenced above.
The countries covered in the biologic imaging reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the biologic imaging reagents market because of the presence of sophisticated healthcare infrastructure, high per capita healthcare expenditure, and patient awareness levels drives the growth of the biologic imaging reagents market within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the presence of high unmet medical needs and growing economic growth supporting healthcare infrastructure improvement in countries such as India and China attributes to this facts in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The biologic imaging reagents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biologic imaging reagents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biologic imaging reagents market. The data is available for historic period 2010-2020.
Competitive Landscape and Biologic Imaging Reagents Market Share Analysis
The biologic imaging reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biologic imaging reagents market.
Some of the major players operating in the biologic imaging reagents market are Thermo Fisher Scientific., PerkinElmer Inc, Guerbet, Beckman Coulter, Inc., BIOPRO Baden-Württemberg GmbH, Bracco Diagnostic Inc.., Bayer, FUJIFILM Visualsonics, Inc., GENERAL ELECTRIC, Cardinal Health, Koninklijke Philips N.V., Siemens, Advanced Proteome, Promega Corporation., and ABX advanced biochemical compounds GmbH among others.